Femme et Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
The aim of this phase I/II trial is to determine the dose of daunorubicine to be associated with cytarabine and Imatinib for induction therapy in patients with chronic myelogenous leukemia in myeloid acute phase.
Critère d'inclusion
- Chronic myeloid leukemia